SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Stateside's Canadian Microcap Board
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ogi who wrote (1640)5/20/2016 4:21:00 AM
From: Dave@SI1 Recommendation

Recommended By
downandout

  Read Replies (3) of 1728
 
BCT - BioNap CRO follow-up article out (presumably paid-for, although his disclaimer does say " accurately reflect my personal views about the subject securities"):
"I'm expecting enrollment to begin in July 2016. ... With proof-of-concept 4-6 months later "

Also discusses a recent failure by a "comparable" trial, ECLIPSE by Aduro, one comment being "Thirdly, BriaCell is targeting specific patients that they believe will have uber-response to BriaVax™ ", let's hope there are enough responders.
He is impressed with Dr Peoples who runs Cancer Insight.

Oddly, despite saying "I believe a significant opportunity exists at today's ground-floor valuation", he does not state anywhere he is long, which his disclaimer says he will do if he is.

And why is it that ayeyou is better at predicting buy-back targets (20c) than I want him to be!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News